OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Monitoring of safety and effectiveness of cladribine in multiple sclerosis patients over 50 years
Giulio Disanto, Marcello Moccia, Rosaria Sacco, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103490-103490
Closed Access | Times Cited: 16
Giulio Disanto, Marcello Moccia, Rosaria Sacco, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103490-103490
Closed Access | Times Cited: 16
Showing 16 citing articles:
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Óscar Fernández, Per Soelberg Sørensen, Gıancarlo Comı, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Óscar Fernández, Per Soelberg Sørensen, Gıancarlo Comı, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
Per Soelberg Sørensen, Luigi Pontieri, Hanna Joensen, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 70, pp. 104491-104491
Open Access | Times Cited: 23
Per Soelberg Sørensen, Luigi Pontieri, Hanna Joensen, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 70, pp. 104491-104491
Open Access | Times Cited: 23
As time goes by: Treatment challenges in elderly people with multiple sclerosis
Stefano Gelibter, Lorenzo Saraceno, Fiammetta Pirro, et al.
Journal of Neuroimmunology (2024) Vol. 391, pp. 578368-578368
Closed Access | Times Cited: 4
Stefano Gelibter, Lorenzo Saraceno, Fiammetta Pirro, et al.
Journal of Neuroimmunology (2024) Vol. 391, pp. 578368-578368
Closed Access | Times Cited: 4
Identifying Cladribine prescription pattern in MS: an Italian multicentre study
Aurora Zanghì, Roberta Fantozzi, Matteo Foschi, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Aurora Zanghì, Roberta Fantozzi, Matteo Foschi, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Management of multiple sclerosis in older adults: review of current evidence and future perspectives
Kimberly DiMauro, Carol Swetlik, Jeffrey A. Cohen
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3794-3805
Open Access | Times Cited: 3
Kimberly DiMauro, Carol Swetlik, Jeffrey A. Cohen
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3794-3805
Open Access | Times Cited: 3
Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
Pierre Clavelou, Giovanni Castelnovo, Valérie Pourcher, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1457-1476
Open Access | Times Cited: 8
Pierre Clavelou, Giovanni Castelnovo, Valérie Pourcher, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 5, pp. 1457-1476
Open Access | Times Cited: 8
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis
de Sèze, Dominique Dive, Xavier Ayrignac, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 519-533
Open Access | Times Cited: 2
de Sèze, Dominique Dive, Xavier Ayrignac, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 519-533
Open Access | Times Cited: 2
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)
Sebastiano Arena, Clara Grazia Chisari, Simona Toscano, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 7, pp. 1271-1283
Closed Access | Times Cited: 4
Sebastiano Arena, Clara Grazia Chisari, Simona Toscano, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 7, pp. 1271-1283
Closed Access | Times Cited: 4
The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets
Helmut Butzkueven, Nicholas Moore, Aida Aydemir, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 7, pp. 1167-1176
Open Access | Times Cited: 6
Helmut Butzkueven, Nicholas Moore, Aida Aydemir, et al.
Current Medical Research and Opinion (2022) Vol. 38, Iss. 7, pp. 1167-1176
Open Access | Times Cited: 6
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
Helmut Butzkueven, Jan Hillert, Merja Soilu‐Hänninen, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 10, pp. 1367-1374
Open Access | Times Cited: 3
Helmut Butzkueven, Jan Hillert, Merja Soilu‐Hänninen, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 10, pp. 1367-1374
Open Access | Times Cited: 3
Sclerosi multipla: trattamenti di base
Jean‐Christophe Ouallet
EMC - Neurologia (2024) Vol. 24, Iss. 3, pp. 1-15
Closed Access
Jean‐Christophe Ouallet
EMC - Neurologia (2024) Vol. 24, Iss. 3, pp. 1-15
Closed Access
Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations
E.M.E. Coerver, Sezgi Kaçar, Olga Ciccarelli, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 10, pp. 1296-1308
Closed Access
E.M.E. Coerver, Sezgi Kaçar, Olga Ciccarelli, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 10, pp. 1296-1308
Closed Access
Sclérose en plaques : traitements de fond
J.-C. Ouallet
EMC - Neurologie (2024) Vol. 47, Iss. 2, pp. 1-15
Closed Access
J.-C. Ouallet
EMC - Neurologie (2024) Vol. 47, Iss. 2, pp. 1-15
Closed Access
Late onset multiple sclerosis
Maja Budimkić, Olivera Tamaš, Nikola D. Veselinovic, et al.
Medicinski podmladak (2024) Vol. 75, Iss. 5, pp. 48-57
Open Access
Maja Budimkić, Olivera Tamaš, Nikola D. Veselinovic, et al.
Medicinski podmladak (2024) Vol. 75, Iss. 5, pp. 48-57
Open Access
The development of multiple sclerosis over the age of 50
N. Yu. Lashch, A E Pavlikov, A. N. Boyko
S S Korsakov Journal of Neurology and Psychiatry (2023) Vol. 123, Iss. 9, pp. 21-21
Closed Access | Times Cited: 1
N. Yu. Lashch, A E Pavlikov, A. N. Boyko
S S Korsakov Journal of Neurology and Psychiatry (2023) Vol. 123, Iss. 9, pp. 21-21
Closed Access | Times Cited: 1
